Biblio Discovery — Demo Discovery Service

48 results for "Adalbert Krawczyk"

Showing 1–20 · 0.33 seconds · RSS

  1. Journal Article

    Role of L-Particles during Herpes Simplex Virus Infection

    Christiane S. Heilingloh; Adalbert Krawczyk

    Frontiers in Microbiology, Vol. 8 · 2017 · English · DOAJ Scopus

    Infection of eukaryotic cells with α-herpesviruses results in the formation and secretion of infectious heavy particles (virions; H-particles) and non-infectious light particles (L-particles). Herpes simplex virus type 1 (HSV-1) H-particles consist of a genome-containing capsid surrounded by…

  2. Journal Article

    HSV-1 Modulates IL-6 Receptor Expression on Human Dendritic Cells

    Alexandra Birzer; Adalbert Krawczyk; Christina Draßner et al.

    Frontiers in Immunology, Vol. 11 · 2020 · English · DOAJ Scopus

    Dendritic cells (DCs) are the guardians of the immune system since they are located in the majority of peripheral tissues. In addition, they are crucial for the induction of an effective immune response based on their unique capacity to stimulate naive T cells. During co-evolution, the human…

  3. Journal Article

    A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds

    Lara Schöler; Vu Thuy Khanh Le-Trilling; Mareike Eilbrecht et al.

    Frontiers in Immunology, Vol. 11 · 2020 · English · DOAJ Scopus

    The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the most pressing medical and socioeconomic challenge. Constituting important correlates of protection, the determination of virus-neutralizing antibodies (NAbs) is…

  4. Journal Article

    Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1

    Isabel Zydek; Laura Thümmler; Nadine Beckmann et al.

    Frontiers in Microbiology, Vol. 16 · 2025 · English · DOAJ Scopus

    IntroductionCOVID-19, caused by SARS-CoV-2, remains a global health challenge despite the availability of vaccines and antiviral treatments. The emergence of immune escape variants and the persistence of long COVID symptoms continue to complicate prevention and therapy, especially in low-resource…

  5. Journal Article Full text

    Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients

    Laura Thümmler; Michael Koldehoff; Neslinur Fisenkci et al.

    Vaccines, Vol. 10 No. 6 · 2022 · English · DOAJ Scopus

    Protecting vulnerable groups from severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection is mandatory. Immune responses after a third vaccination against SARS-CoV-2 are insufficiently studied in patients after hematopoietic stem-cell transplantation (HSCT). We analyzed immune…

  6. Journal Article Full text

    Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses

    Lukas van de Sand; Maren Bormann; Yasmin Schmitz et al.

    Viruses, Vol. 13 No. 7 · 2021 · English · DOAJ Scopus

    Herpes simplex viruses (HSV) are ubiquitously distributed with a seroprevalence ranging up to 95% in the adult population. Refractory viral infections with herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) represent a major global health issue. In particular, the increasing occurrence of…

  7. Journal Article

    Superior antiviral activity of IFNβ in genital HSV-1 infection

    Yasmin Schmitz; Mara Schwerdtfeger; Jaana Westmeier et al.

    Frontiers in Cellular and Infection Microbiology, Vol. 12 · 2022 · English · DOAJ Scopus

    Type I interferons (IFNs) present the first line of defense against viral infections, providing antiviral, immunomodulatory and antiproliferative effects. The type I IFN family contains 12 IFNα subtypes and IFNβ, and although they share the same receptor, they are classified as non-redundant…

  8. Journal Article Full text

    Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant Recipients

    Monika Lindemann; Charleen Baumann; Benjamin Wilde et al.

    Vaccines, Vol. 10 No. 6 · 2022 · English · DOAJ Scopus

    Solid organ transplant recipients have an up to ninefold higher risk of varicella–zoster virus (VZV) reactivation than the general population. Due to lifelong immunosuppressive therapy, vaccination against VZV may be less effective in kidney transplant (KTX) recipients. In the current study, twelve…

  9. Journal Article Full text

    Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic Cells

    Linda Grosche; Petra Mühl-Zürbes; Barbara Ciblis et al.

    Viruses, Vol. 12 No. 1 · 2020 · English · DOAJ Scopus

    Herpes simplex viruses not only infect a variety of different cell types, including dendritic cells (DCs), but also modulate important cellular functions in benefit of the virus. Given the relevance of directed immune cell migration during the initiation of potent antiviral immune responses…

  10. Journal Article

    Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages

    André Görgens; Anna-Kristin Ludwig; Michael Möllmann et al.

    Stem Cell Reports, Vol. 3 No. 6 · 2014 · English · DOAJ Scopus

    Hematopoietic stem and progenitor cells (HSPCs) can self-renew and create committed progenitors, a process supposed to involve asymmetric cell divisions (ACDs). Previously, we had linked the kinetics of CD133 expression with ACDs but failed to detect asymmetric segregation of classical CD133…

  11. Journal Article

    Antibody responses after sequential vaccination with PCV13 and PPSV23 in patients with moderate to severe plaque psoriasis under immunosuppressive therapy

    Lorena Helmer; Lukas van de Sand; Thea Wojtakowski et al.

    mBio, Vol. 15 No. 7 · 2024 · English · DOAJ Scopus

    ABSTRACT A crucial step in lowering the risk of invasive pneumococcal illness in high-risk populations, such as individuals with plaque psoriasis, is pneumococcal vaccination. The serologic response to the sequential vaccination with Prevenar 13 (PCV13) and Pneumovax 23 (PPSV23) in psoriasis…

  12. Journal Article

    Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment

    Laura Thümmler; Margarethe Konik; Monika Lindemann et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    Immunocompromised patients are at increased risk for a severe course of COVID-19. Treatment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection with anti-SARS-CoV-2 monoclonal antibodies (mAbs) has become widely accepted. However, the effects of mAb treatment on the long-term…

  13. Journal Article

    Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy

    Michel Bazinet; Victor Pântea; Gheorghe Plăcintă et al.

    Gastroenterology · 2020 · English · OpenAlex Scopus

    BACKGROUND & AIMS: Nucleic acid polymers (NAPs) inhibit assembly and secretion of hepatitis B virus (HBV) subviral particles. We performed an open-label, phase 2 study of the safety and efficacy of the NAPs REP 2139 or REP 2165 combined with tenofovir disoproxil fumarate (TDF) and pegylated…

  14. Journal Article

    Long-term persistence of pneumococcal antibodies 5 years after a sequential PCV13 and PPSV23 vaccination in kidney transplant recipients: indications for revaccination

    Lukas van de Sand; Monika Lindemann; Kim L. Völk et al.

    mSphere, Vol. 11 No. 3 · 2026 · English · DOAJ Scopus

    ABSTRACT Pneumococcal vaccination is essential to prevent invasive Streptococcus pneumoniae infections in immunocompromised individuals, including kidney transplant recipients. Current recommendations favor single-dose immunization with higher-valent conjugate vaccines, including PCV20 or PCV21…

  15. Journal Article Full text

    Evaluation of T-Cell Responses Following Sequential Vaccination with PCV13 and PPSV23 Against Streptococcus pneumoniae in Patients with Psoriasis

    Thea Wojtakowski; Lukas van de Sand; Lorena Helmer et al.

    Vaccines, Vol. 13 No. 9 · 2025 · English · DOAJ Scopus

    Background: Characterization of cellular responses to vaccinations in immunocompromised patients remains an evolving area of research. This particularly applies for pneumococcal vaccination in diseases such as psoriasis and in the setting of immunosuppressive therapy. Methods: This prospective…

  16. Journal Article Full text

    False-Positive Screening and Confirmatory HIV Diagnostic Test in a Patient with Cured SARS-CoV-2 Infection Is Not Mediated by Env/Spike Cross-Reactive Antibodies

    Carina Elsner; Gwenllian A. Appeltrath; Margarethe Konik et al.

    Viruses, Vol. 15 No. 5 · 2023 · English · DOAJ Scopus

    Acute SARS-CoV-2 infection has been associated with false-positive HIV screening tests. The underlying mechanism is unclear, and for clinical cases, evidence beyond a temporal connection is missing. However, several experimental studies point toward SARS-CoV-2 spike/HIV-1 envelope (Env)…

  17. Journal Article

    Dose-dependent antiviral effects of glycyrrhizin, curcumin, and harmaline against clinical SARS-CoV-2 isolates, including D614G, Omicron BA.5, and Omicron XBB.1

    Rabea Grüneberg; Isabel Zydek; Carina Elsner et al.

    BMC Complementary Medicine and Therapies, Vol. 26 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background SARS-CoV-2 remains a major global health challenge, as infection can lead to potential life-threatening conditions such as COVID-19. Emerging variants of the virus are characterized by higher transmission rates and immune escape mutations, enabling them to evade vaccine-induced…